To explore the clinical implications of RR subunits, we compared the differences of RRM1, RRM2, and RRM2B among clinicopathologic features, including age, race, gender, T stage, grade, stage, tumor status, and alpha-fetoprotein (AFP) level. This evidence concerns the gene RRM2 and neoplasm.